title: Role of adrenoceptors in vasopressin, oxytocin and prolactin responses to conditioned fear stimuli in the rat.
abstract: Conditioned fear or novel environmental stimuli suppress vasopressin (VP) and augment oxytocin (OT) and prolactin (PRL) release in rats. We examined the effects of intracerebroventricular (i.c.v.) injections of adrenoceptor antagonists on these neuroendocrine responses to conditioned fear or novel environmental stimuli in male rats. A beta1 antagonist, metoprolol, blocked the VP but not the OT or PRL response to conditioned fear stimuli, but did not abolish neuroendocrine responses to novel environmental stimuli. A beta2 antagonist, ICI118551, impaired the PRL but not the VP or OT response to fear or novel environmental stimuli. In rats injected with a alpha1 adrenoceptor antagonist, benoxathian, conditioned fear stimuli did not significantly induce the VP, OT or PRL responses. The effects of benoxathian were not due to a general reduction of arousal, since benoxathian did not prevent the VP, OT or PRL response to novel environmental stimuli. These data suggest that beta1 adrenoceptors play a selective role in the VP response to conditioned fear stimuli, as do beta2 adrenoceptors in the prolactin response to conditioned fear and novel environmental stimuli. We conclude that alpha1 adrenoceptors play a facilitative role in VP, OT, PRL responses to conditioned fear stimuli.
authors.affiliation: Department of Physiology, Jichi Medical School, Japan.
authors.forename: C J
authors.initials: CJ
authors.lastname: Zou
authors.forename: T
authors.initials: T
authors.lastname: Onaka
authors.forename: K
authors.initials: K
authors.lastname: Yagi
mesh_terms: D018674:Adrenergic Antagonists / Q000008:administration & dosage / Q000494:pharmacology; D000818:Animals; D003213:Conditioning, Psychological; D004777:Environment; D005239:Fear / Q000502:physiology*; D007276:Injections, Intraventricular; D008297:Male; D008790:Metoprolol / Q000008:administration & dosage / Q000494:pharmacology; D010075:Oxathiins / Q000008:administration & dosage / Q000494:pharmacology; D010121:Oxytocin / Q000097:blood*; D011388:Prolactin / Q000097:blood*; D011412:Propanolamines / Q000008:administration & dosage / Q000494:pharmacology; D051381:Rats; D017208:Rats, Wistar; D011941:Receptors, Adrenergic / Q000502:physiology*; D018340:Receptors, Adrenergic, alpha-1 / Q000502:physiology; D018342:Receptors, Adrenergic, beta-1 / Q000502:physiology; D018343:Receptors, Adrenergic, beta-2 / Q000502:physiology; D013312:Stress, Physiological / Q000503:physiopathology; D014667:Vasopressins / Q000097:blood*
chemical_list: D018674:Adrenergic Antagonists; D010075:Oxathiins; D011412:Propanolamines; D011941:Receptors, Adrenergic; D018340:Receptors, Adrenergic, alpha-1; D018342:Receptors, Adrenergic, beta-1; D018343:Receptors, Adrenergic, beta-2; D014667:Vasopressins; C026777:ICI 118551; D010121:Oxytocin; D011388:Prolactin; C050877:benoxathian; D008790:Metoprolol